Institute of Biomedical Research Corp. (MRES)
USD 0.01
(-26.32%)
USD 0.01
(-26.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2010 | -239.15 Thousand USD | 40.03% |
| 2009 | -239.15 Thousand USD | 92.5% |
| 2008 | -398.78 Thousand USD | -549.2% |
| 2007 | -5.32 Million USD | -762.35% |
| 2006 | -95.03 Thousand USD | 0.0% |
| 2004 | -14.57 Thousand USD | -27.04% |
| 2003 | -11.47 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2010 Q2 | -552.27 Thousand USD | -407.51% |
| 2010 Q3 | -23.02 Thousand USD | 95.83% |
| 2010 Q4 | -5181.00 USD | 77.5% |
| 2010 Q1 | -108.82 Thousand USD | -17.39% |
| 2010 FY | - USD | 40.03% |
| 2009 Q2 | -24.17 Thousand USD | 83.12% |
| 2009 FY | - USD | 92.5% |
| 2009 Q3 | -13.45 Thousand USD | 44.35% |
| 2009 Q1 | -143.23 Thousand USD | -84.69% |
| 2009 Q4 | -92.69 Thousand USD | -589.01% |
| 2008 Q1 | -4.69 Million USD | -2624.53% |
| 2008 Q4 | -77.55 Thousand USD | 5.81% |
| 2008 Q3 | -82.33 Thousand USD | 13.93% |
| 2008 Q2 | -95.66 Thousand USD | 97.96% |
| 2008 FY | - USD | -549.2% |
| 2007 Q2 | -147.68 Thousand USD | 81.47% |
| 2007 FY | - USD | -762.35% |
| 2007 Q4 | -172.48 Thousand USD | 42.19% |
| 2007 Q3 | -298.37 Thousand USD | -102.04% |
| 2007 Q1 | -797.13 Thousand USD | -20381.24% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | -3892.00 USD | 73.35% |
| 2006 Q3 | -14.6 Thousand USD | -263.69% |
| 2006 Q2 | -4015.00 USD | 92.93% |
| 2006 Q1 | -56.78 Thousand USD | -156.24% |
| 2005 Q3 | -136.41 Thousand USD | -2241.82% |
| 2005 Q4 | 100.95 Thousand USD | 174.01% |
| 2005 Q2 | -5825.00 USD | -299.25% |
| 2005 Q1 | -1459.00 USD | 22.89% |
| 2004 Q3 | -1042.00 USD | 85.34% |
| 2004 Q2 | -7106.00 USD | -79.72% |
| 2004 FY | - USD | -27.04% |
| 2004 Q4 | -1892.00 USD | -81.57% |
| 2004 Q1 | -3954.00 USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 99.663% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 95.966% |
| SQZ Biotechnologies Company | -64.14 Million USD | 99.627% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 98.623% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 100.254% |
| Mesoblast Limited | -62.38 Million USD | 99.617% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 84.431% |
| Genus plc | 73.7 Million USD | 100.324% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 96.383% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 93.258% |
| Marizyme, Inc. | -34.28 Million USD | 99.302% |
| ContraFect Corporation | -64.99 Million USD | 99.632% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 97.274% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 94.716% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 82.94% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 90.957% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 89.709% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 53.836% |
| Accustem Sciences Inc. | -3.74 Million USD | 93.617% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 99.504% |
| EV Biologics, Inc. | -1.26 Million USD | 81.127% |
| Q BioMed Inc. | -617.62 Thousand USD | 61.279% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 106.695% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 62.184% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 89.532% |
| Biomind Labs Inc. | -1.03 Million USD | 76.884% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 102.421% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 96.661% |
| Skye Bioscience, Inc. | -13.54 Million USD | 98.235% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 83.922% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -856.6% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 93.843% |
| IMV Inc. | -35.52 Million USD | 99.327% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 98.493% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 90.442% |
| GB Sciences, Inc. | -1.41 Million USD | 83.157% |
| Alpha Cognition Inc. | -9.7 Million USD | 97.536% |
| HST Global, Inc. | -5303.00 USD | -4409.711% |
| CSL Limited | 4.78 Billion USD | 100.005% |
| Halberd Corporation | -74.27 Thousand USD | -221.962% |
| Enzolytics Inc. | -2.12 Million USD | 88.73% |
| Resverlogix Corp. | -11.74 Million USD | 97.963% |
| Affymax, Inc. | -14.29 Million USD | 98.327% |
| SYBLEU INC | -141.57 Thousand USD | -68.926% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 92.192% |
| argenx SE | -216.02 Million USD | 99.889% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 99.568% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 119.651% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 84.045% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 163.126% |
| AVAX Technologies, Inc. | -6.11 Million USD | 96.088% |
| Zenith Capital Corp. | -8.6 Million USD | 97.221% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.904% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -1272.768% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 90.225% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -35.862% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 99.397% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 91.732% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 77.144% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 3656.663% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 86.334% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 87.55% |
| BioStem Technologies, Inc. | -7.55 Million USD | 96.834% |
| ONE Bio Corp. | 13.61 Million USD | 101.757% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -32.063% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 88.374% |
| Agentix Corp. | -1.37 Million USD | 82.566% |
| LadRx Corporation | 412.28 Thousand USD | 158.006% |
| Cell Source, Inc. | -4.27 Million USD | 94.403% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 34.876% |
| Regen BioPharma, Inc. | 1.46 Million USD | 116.314% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 74.476% |
| NovAccess Global Inc. | -1.03 Million USD | 76.889% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 102.701% |
| Itoco Inc. | -1.86 Million USD | 87.204% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 37.003% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 78.571% |
| Kadimastem Ltd | -2.62 Million USD | 90.887% |
| Oncology Pharma Inc. | - USD | Infinity% |
| CytoDyn Inc. | -18.02 Million USD | 98.674% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -202.61% |
| Mobile Lads Corp. | -2.24 Million USD | 89.329% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -1855.597% |
| Qrons Inc. | -40.08 Thousand USD | -496.667% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 50.76% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 145.342% |
| Rebus Holdings, Inc. | -951 Thousand USD | 74.853% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 77.481% |
| International Stem Cell Corporation | 202 Thousand USD | 218.391% |
| Bioxytran, Inc. | -3.82 Million USD | 93.74% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -354.312% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 90.286% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 99.333% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -431.444% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 91.266% |
| Neutra Corp. | -181.24 Thousand USD | -31.947% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 98.814% |
| PureTech Health plc | -11.62 Million USD | 97.943% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 98.814% |
| IXICO plc | -707 Thousand USD | 66.174% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 96.888% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 99.505% |
| CSL Limited | 4.73 Billion USD | 100.005% |
| Cellectis S.A. | -92.63 Million USD | 99.742% |